Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Buck

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Psychotherapy and Psychosomatics|May 11, 2017
Altered Dopamine Responses to Monetary Rewards in Female Fibromyalgia Patients with and without Depression: A [11C]Raclopride Bolus-plus-Infusion PET StudyKatharina Ledermann, Josef Jenewein, Haiko Sprott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivoTobias von Lukowicz, Michela Silacci, Matthias T Wyss, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomographyFunda Akkus, Simon M Ametamey, Valerie Treyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 19, 2007
Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methodsValerie Treyer, Johannes Streffer, Matthias T Wyss, et al.
EJNMMI Research|June 27, 2019
Radiation dosimetry of [<sup>18</sup>F]-PSS232-a PET radioligand for imaging mGlu5 receptors in humansBert-Ram Sah, Michael Sommerauer, Linjing Mu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2017
A first-in-man PET study of [<sup>18</sup>F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5Geoffrey Warnock, Michael Sommerauer, Linjing Mu, et al.
Nuclear Medicine and Biology|October 7, 2004
Influence of ceftriaxone treatment on FDG uptake--an in vivo [18F]-fluorodeoxyglucose imaging study in soft tissue infections in ratsMatthias T Wyss, Michael Honer, Nicolas Späth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5Simon M Ametamey, Lea J Kessler, Michael Honer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 1, 2024
Gray matter gamma-hydroxy-butyric acid and glutamate reflect beta-amyloid burden at old ageSimon J Schreiner, Jiri M G Van Bergen, Anton F Gietl, et al.
Clinical Imaging|February 16, 2018
Value of <sup>18</sup>F-FET PET in adult brainstem gliomaAbdulrahman Abdullah Albatly, Adnan Taleb Alsamarah, Abdulrahman Alhawas, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Psychotherapy and Psychosomatics|May 11, 2017
Altered Dopamine Responses to Monetary Rewards in Female Fibromyalgia Patients with and without Depression: A [11C]Raclopride Bolus-plus-Infusion PET StudyKatharina Ledermann, Josef Jenewein, Haiko Sprott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivoTobias von Lukowicz, Michela Silacci, Matthias T Wyss, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomographyFunda Akkus, Simon M Ametamey, Valerie Treyer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 19, 2007
Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methodsValerie Treyer, Johannes Streffer, Matthias T Wyss, et al.
EJNMMI Research|June 27, 2019
Radiation dosimetry of [<sup>18</sup>F]-PSS232-a PET radioligand for imaging mGlu5 receptors in humansBert-Ram Sah, Michael Sommerauer, Linjing Mu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2017
A first-in-man PET study of [<sup>18</sup>F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5Geoffrey Warnock, Michael Sommerauer, Linjing Mu, et al.
Nuclear Medicine and Biology|October 7, 2004
Influence of ceftriaxone treatment on FDG uptake--an in vivo [18F]-fluorodeoxyglucose imaging study in soft tissue infections in ratsMatthias T Wyss, Michael Honer, Nicolas Späth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5Simon M Ametamey, Lea J Kessler, Michael Honer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 1, 2024
Gray matter gamma-hydroxy-butyric acid and glutamate reflect beta-amyloid burden at old ageSimon J Schreiner, Jiri M G Van Bergen, Anton F Gietl, et al.
Clinical Imaging|February 16, 2018
Value of <sup>18</sup>F-FET PET in adult brainstem gliomaAbdulrahman Abdullah Albatly, Adnan Taleb Alsamarah, Abdulrahman Alhawas, et al.
Pageof 12